NIH Changes Terms and Conditions Governing Federal Grants
The National Institutes of Health announced a significant change to the terms and conditions governing federal funding applicable to all NIH grants, cooperative agreements and other awards, including future awards.
FDA Requires Major Changes to Opioid Pain Medication Labeling
The U.S. Food and Drug Administration is requiring safety labeling changes to all opioid pain medications to better emphasize and explain the risks associated with their long-term use.
HHS Cuts Funding for mRNA Vaccine Research
The U.S. Department of Health and Human Services (HHS) has begun a coordinated wind-down of its mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority (BARDA).
New Data Show One in 31 Kids Has Autism
Autism prevalence in the U.S. has increased from one in 36 children to one in 31, according to the Centers for Disease Control and Prevention’s (CDC) latest Autism and Developmental Disabilities Monitoring (ADDM) Network survey.
University of Toledo Awarded Funds to Explore Immune Response to Oral Thrush
The University of Toledo will receive $473,632 from the National Institute of Dental and Craniofacial Research to explore how the body’s immune system responds to the condition known as oral thrush.
Draft Budget Proposal Would Cut HHS Federal Health Programs by One-Third
A draft budget proposal circulating among federal officials suggests a cut in the U.S. Department of Health and Human Services’ discretionary spending by as much as one-third, or tens of billions of dollars.
HHS and NIH Invest in Universal Vaccine Platform for Pandemic-Prone Viruses
The U.S. Department of Health and Human Services (HHS) and the National Institutes of Health (NIH) have announced the development of the next-generation, universal vaccine platform, Generation Gold Standard, using a beta-propiolactone (BPL)-inactivated, whole-virus platform.
CMS Releases Proposed 2026 Payment Policy Updates for MA and Part D Programs
The Centers for Medicare and Medicaid Services released the 2026 Advance Notice for the Medicare Advantage and the Medicare Part D Prescription Drug Programs that would update payment policies for these programs.
HHS Announces 15 Additional Drugs for Price Negotiations
The Centers for Medicare and Medicaid Services (CMS) has announced the selection of 15 additional drugs covered under Medicare Part D for price negotiations.
Grant Allows UCLA to Launch Autoimmunity Center to Find Cures
The National Institutes of Health has awarded a $3.4 million grant to help establish a new Autoimmunity Center of Excellence at the University of California, Los Angeles.